A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2001

Conditions
HIV InfectionsPregnancy
Interventions
DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

Trial Locations (20)

12208

Children's Hosp at Albany Med Ctr, Albany

13210

SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse

20060

Howard Univ Hosp, Washington D.C.

32209

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville

33136

Univ of Miami / Jackson Memorial Hosp, Miami

33161

Univ of Miami (Pediatric), Miami

38103

Regional Med Ctr at Memphis, Memphis

90033

Los Angeles County - USC Med Ctr, Los Angeles

191341095

Temple Univ School of Medicine, Philadelphia

277103499

Duke Univ Med Ctr, Durham

381052794

Saint Jude Children's Research Hosp of Memphis, Memphis

606371470

Univ of Chicago Children's Hosp, Chicago

900951752

UCLA Med Ctr / Pediatric, Los Angeles

905022004

Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles

981050371

Children's Hospital & Medical Center / Seattle ACTU, Seattle

021155724

Children's Hosp of Boston, Boston

02115

Brigham and Women's Hosp, Boston

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

009365067

Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan

009367344

San Juan City Hosp, San Juan

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH